Ireland
--:--IST
Priya Life Science Medicines register
Registers› Irish medicines ›Flutiform 250 microgram/10 microgram per metered dose pressurised inhalation, suspension
Medicines register · Ireland

Flutiform 250 microgram/10 microgram per metered dose pressurised inhalation, suspension

Authorisation PPA1463/138/001 · IMED Healthcare Ltd.,

Source: Health Products Regulatory Authority (HPRA), open dataset, CC BY 4.0. HPRA list dated 22 Nov 2026
Licence holder
IMED Healthcare Ltd., (all products →)
Active substances
Fluticasone propionate, Formoterol fumarate
Clinical trials
2 clinical trials →
Dosage form
Pressurised inhalation, suspension
Route of administration
Inhalation use
ATC codes
R03AK, R03AK11
First authorised
02/10/2020
Prescription status
Product subject to prescription which may be renewed (B)
Supply
Supply through pharmacies only
Legal basis
Parallel importation notified in accordance with Article 76(3) of Directive 2001/83/EC

Fluticasone propionate: supply and approvals

72 authorised products on the HPRA list contain Fluticasone propionate. Shortage records below are for the substance in the EU, US and German markets and may not affect this Irish product; for Irish supply, check with the HPRA or a pharmacist.

EU shortage (EMA)
No entry in the EMA shortage catalogue (checked 21 Nov 2026)
US shortage (FDA)
No entry in the FDA drug shortage list (checked 21 Nov 2026)
Germany (BfArM)
No entry in the BfArM supply notices (checked 21 Nov 2026)

Registers: EU shortages · US shortages · German shortages · EMA approvals

Formoterol fumarate: supply and approvals

35 authorised products on the HPRA list contain Formoterol fumarate. Shortage records below are for the substance in the EU, US and German markets and may not affect this Irish product; for Irish supply, check with the HPRA or a pharmacist.

EU shortage (EMA)
No entry in the EMA shortage catalogue (checked 21 Nov 2026)
US shortage (FDA)
No entry in the FDA drug shortage list (checked 21 Nov 2026)
Germany (BfArM)
No entry in the BfArM supply notices (checked 21 Nov 2026)

Registers: EU shortages · US shortages · German shortages · EMA approvals

About this licence

Parallel import (PPA). A parallel product authorisation: the HPRA allows this product to be imported from another EU or EEA country and sold in Ireland. It has been authorised for 6 years (since 2 October 2020). The HPRA list does not say whether it is on sale.

Other medicines with Fluticasone propionate in Ireland

71 other products on the HPRA list contain Fluticasone propionate, from 16 licence holders; 27 of them are marked as marketed. Products with the same substance can differ in strength, form, other ingredients and what they are licensed for, so they are not automatically interchangeable.

MedicineLicence holderLicenceStatus
AirFluSal Forspiro 50 microgram/250 microgram/dose, inhalation powder, predispensedRowex Limited,National authorisation (PA)Marketed
AirFluSal Forspiro 50 microgram/500 microgram/dose, inhalation powder, predispensedRowex Limited,National authorisation (PA)Marketed
Azecort 137 micrograms/50 micrograms per actuation nasal spray, suspensionViatris Healthcare LimitedNational authorisation (PA)Marketed
Azelastine hydrochloride /Fluticasone propionate Rowex 137 micrograms/50 micrograms per actuation, nasal spray suspensionRowex Limited,National authorisation (PA)Marketed
Dymista 137 micrograms/50 micrograms per actuation, Nasal Spray SuspensionViatris Healthcare LimitedNational authorisation (PA)Marketed
Flixonase Allergy Relief 50 micrograms per dose Nasal SprayHaleon Ireland LimitedNational authorisation (PA)Marketed
Flixotide Diskus 100 micrograms, Inhalation Powder, pre-dispensedGlaxoSmithKline (Ireland) LimitedNational authorisation (PA)Marketed
Flixotide Diskus 250 micrograms, Inhalation Powder, pre-dispensedGlaxoSmithKline (Ireland) LimitedNational authorisation (PA)Marketed
Flixotide Diskus 50 micrograms, Inhalation Powder, pre-dispensedGlaxoSmithKline (Ireland) LimitedNational authorisation (PA)Marketed
Flixotide Diskus 500 micrograms, Inhalation Powder, pre-dispensedGlaxoSmithKline (Ireland) LimitedNational authorisation (PA)Marketed
Flixotide Evohaler 125 micrograms per metered dose Pressurised Inhalation SuspensionGlaxoSmithKline (Ireland) LimitedNational authorisation (PA)Marketed
Flixotide Evohaler 250 micrograms per metered dose Pressurised Inhalation, SuspensionGlaxoSmithKline (Ireland) LimitedNational authorisation (PA)Marketed

All 72 products with Fluticasone propionate →

Other medicines with Formoterol fumarate in Ireland

2 other products on the HPRA list contain Formoterol fumarate, from 2 licence holders; 0 of them are marked as marketed. Products with the same substance can differ in strength, form, other ingredients and what they are licensed for, so they are not automatically interchangeable.

MedicineLicence holderLicenceStatus
Flutiform 125 microgram/5 microgram per metered dose pressurised inhalation, suspensionIMED Healthcare Ltd.,Parallel import (PPA)Not stated
Formoterol 12 micrograms inhalation powder, hard capsuleLaboratorios LICONSA, S.A.National authorisation (PA)Not marketed

Other substances in ATC group R03AK

The ATC system groups medicines by the part of the body they act on and their chemistry. On the HPRA list, 12 other active substances share the group R03AK with this product:

Salmeterol (14) · Formoterol fumarate dihydrate (11) · SALMETEROL XINAFOATE (8) · Budesonide (7) · Beclometasone dipropionate (2) · Beclometasone dipropionate anhydrous (1) · Fluticasone furoate (1) · Vilanterol (1) · Formoterol fumarate dihydrate (micronised) (1) · Formoterol fumatrate dihydrate (1) · Ipratropium bromide monohydrate (1) · Salbutamol (1)

Numbers in brackets are products on the HPRA list. Sharing an ATC group does not mean two medicines can replace each other.

The licence holder

IMED Healthcare Ltd., holds 183 products on the HPRA list, with 122 different active substances; 1 of the products is marked as marketed.

Shortages and approvals, every Friday

One email a week with ongoing EU and US medicine shortages, new EMA and FDA approvals and clinical trials recruiting in Ireland.

Free. Unsubscribe from any email with one click. See our privacy policy.

This listing is regulatory information, not medical advice — consult the package leaflet, SPC, or a healthcare professional. For the authoritative record see the HPRA register.

How this page is built

The facts on this page are pulled directly from the HPRA's (Health Products Regulatory Authority) official open dataset — they are not written from memory, and nothing here is summarised or edited. Each field below names the dataset it came from, so you can check it yourself.

This page is built automatically: a daily sync job downloads HPRA's published XML export and copies the licence number, holder, active substance(s), dosage form, route, ATC code(s), authorisation date and prescription status directly into this page — no AI drafting and no per-product editorial pass. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The HPRA data on this page was last retrieved on 22 Nov 2026. How every register is built: methodology · fixes we have made: corrections log.

Please verify before you rely on this. This page is general information for life-science and pharmaceutical professionals. It is not medical advice, and it has not been reviewed by a clinician — our editorial team holds life-science qualifications, not clinical ones. It is not exhaustive and may not reflect the most recent label change. Always check the official prescribing information (US Prescribing Information or EU SmPC) and speak to your doctor or pharmacist before acting on anything here. Drugs in the same class are not automatically interchangeable, and approvals, brand names and indications differ between the US, the EU/Ireland (EMA/HPRA) and other regions. Spotted an error? Tell us — we correct promptly and log it.